news Monitoring ESR1 Mutations May Optimize Treatment in Metastatic Breast Cancer Monitoring bESR1mut enabled optimization of the endocrine therapy used with a CDK4/6 inhibitor. By Andrea S. Blevins Primeau, PhD, MBA Publish Date December 13, 2021